Patents Assigned to GENCLIS
  • Molecular origin of allergy
    Patent number: 11234445
    Abstract: The present invention relates to compositions and methods for modulating or detecting allergy in a subject. The invention may be used to reduce allergenicity of compositions, such as food products, or to stimulate immunogenicity of products, such as vaccines by removal of cationic proteins resulting from transcription infidelity. The invention may be used in any mammal such as human.
    Type: Grant
    Filed: March 20, 2017
    Date of Patent: February 1, 2022
    Assignee: GENCLIS
    Inventors: Bernard Bihain, Virginie Ogier, Marie Brulliard, Sandrine Jacquenet, Benoit Thouvenot, Olivier Roitel